Investors ready to resuscitate Johnson & Johnson's ailing stock

NEW YORK (Reuters) – Johnson & Johnson shareholders have endured a painful year amid worries about prospects for its many businesses, but investors capitalizing on the stock’s relatively cheap valuation may be set to apply a Band-Aid to the declines.


Source: Reuters

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>